IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.049
EU - Europa 3.259
AS - Asia 1.812
SA - Sud America 268
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 94
OC - Oceania 8
Totale 9.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.959
RU - Federazione Russa 769
IT - Italia 652
SG - Singapore 562
GB - Regno Unito 538
CN - Cina 535
IE - Irlanda 403
VN - Vietnam 266
BR - Brasile 207
SE - Svezia 183
DE - Germania 153
UA - Ucraina 148
FR - Francia 145
HK - Hong Kong 136
FI - Finlandia 81
IN - India 62
CA - Canada 59
KR - Corea 56
BD - Bangladesh 52
ZA - Sudafrica 49
ES - Italia 36
NL - Olanda 26
PL - Polonia 24
AR - Argentina 22
BE - Belgio 21
TR - Turchia 19
LU - Lussemburgo 18
JP - Giappone 15
MX - Messico 15
IQ - Iraq 13
PK - Pakistan 13
CL - Cile 12
CI - Costa d'Avorio 11
AT - Austria 9
IR - Iran 9
NG - Nigeria 9
LT - Lituania 8
RO - Romania 8
VE - Venezuela 8
CO - Colombia 7
CR - Costa Rica 7
ID - Indonesia 7
JO - Giordania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
MA - Marocco 6
PH - Filippine 6
TH - Thailandia 6
AU - Australia 5
EC - Ecuador 5
MY - Malesia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
GT - Guatemala 4
KZ - Kazakistan 4
TN - Tunisia 4
UZ - Uzbekistan 4
DK - Danimarca 3
KE - Kenya 3
NO - Norvegia 3
TW - Taiwan 3
AL - Albania 2
CD - Congo 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
MW - Malawi 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NP - Nepal 1
QA - Qatar 1
RS - Serbia 1
Totale 9.487
Salva come PNG Salva come JPEG
Città #
Dallas 515
Southend 455
Dublin 399
Fairfield 380
Ashburn 344
Singapore 329
San Jose 242
Moscow 231
Santa Clara 190
Woodbridge 166
Chandler 158
Milan 152
Beijing 138
Cambridge 138
Wilmington 138
Seattle 133
Ann Arbor 127
Hong Kong 126
Jacksonville 126
Houston 113
Siena 88
New York 84
Council Bluffs 79
Los Angeles 79
Ho Chi Minh City 78
Hefei 68
Princeton 68
Hanoi 64
Munich 53
Seoul 53
Rome 52
Johannesburg 49
Lauterbourg 46
Shanghai 42
Helsinki 38
Columbus 36
Florence 36
Nanjing 35
The Dalles 32
Dong Ket 29
San Mateo 28
Málaga 24
São Paulo 23
San Diego 22
Boardman 21
Buffalo 21
Brussels 20
Montreal 19
Orem 19
London 17
San Francisco 17
Turku 17
Warsaw 17
Shenyang 16
Chicago 14
Denver 14
Roodt-sur-Syre 14
Chennai 13
Da Nang 13
Figino 13
Tokyo 13
Frankfurt am Main 12
Redondo Beach 12
Abidjan 11
Haiphong 11
Nuremberg 11
Phoenix 11
Brooklyn 10
Guangzhou 10
Kunming 10
Toronto 10
Atlanta 9
Baghdad 9
Jiaxing 9
Manchester 9
Pisa 9
Santiago 9
Abuja 8
Arezzo 8
Tianjin 8
Amsterdam 7
Boston 7
Düsseldorf 7
Mexico City 7
Mumbai 7
Nanchang 7
Poplar 7
Portsmouth 7
Bengaluru 6
Dearborn 6
Fremont 6
Hebei 6
North Bergen 6
Redwood City 6
Venezia 6
Washington 6
Zanjan 6
Zhengzhou 6
Amman 5
Aosta 5
Totale 6.396
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 327
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 324
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 321
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 312
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 301
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 288
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 281
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 274
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 272
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 271
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 270
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 269
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 266
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 264
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 261
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 256
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 226
Gemcitabine (dFdC), 5-flurouracil (5FU), and folinic acid (FA) in the treatment of patients with gastro-enteric carcinomas: A clinical and pharmacological study 224
Gastric cancer: Current status of lymph node dissection 223
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 215
Impact of HER2 and microsatellite instability status on response to neoadjuvant/conversion therapy and survival in patients with gastric cancer 211
Short-term and long-term risk factors in gastric cancer 205
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 204
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 199
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 191
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 189
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 176
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 174
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 173
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 159
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 157
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 157
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 155
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 148
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 146
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 132
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 129
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 127
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 126
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 125
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 121
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 109
Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Malignancies with Palliative and Bidirectional Intent 100
null 98
Rare variants modulating phenotype in NF1 carriers 96
null 96
null 89
null 88
null 87
null 39
Totale 9.651
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022459 0 0 37 33 22 29 24 31 23 50 84 126
2022/2023683 39 53 98 66 62 149 23 58 65 32 21 17
2023/2024701 27 15 70 38 26 173 220 9 0 32 45 46
2024/20251.263 58 67 123 87 163 90 29 77 135 44 144 246
2025/20263.714 254 429 425 444 745 151 449 95 121 205 135 261
2026/2027349 175 79 95 0 0 0 0 0 0 0 0 0
Totale 9.651